What does this source bring?
ATOM2 compared the atropine concentrations of 0,5%, 0,1% and 0,01%; lower concentrations had a milder visual symptom profile.
No parallel placebo arm. The historical placebo with ATOM1 is not an equivalent random comparator.
CLAIM-ATOM2Scope of testing and verification
- The role of the record
- Source of the claim
- Population
- Children 6–12 years old, Singapore
- N
- 400
- Geography
- Singapore
- Observation (months)
- 24
- Comparator
- Three concentrations of atropine
- Result
- ATOM2 compared the atropine concentrations of 0,5%, 0,1% and 0,01%; lower concentrations had a milder visual symptom profile.
- Safety
- This record does not allow estimation of the frequency of rare adverse events.
- Device/structure
- Not applicable / not determined within the verified range
- Publisher of the publication
- Elsevier BV
- Financing
- Not determined within the proven range; see the declaration in full text.
- Conflicts of interest
- Not determined within the proven range. The absence of confirmation does not mean the absence of conflict.
- DOI
- 10.1016 /j.ophtha. 2011.07.031
- PMID
- 21963266
- What was checked
- Bibliographic metadata and abstract in Europe PMC / PubMed; Crossref metadata
- Date of verification
- 2026-09-09
This is the editorial card of the publication. The description does not replace the full text, supplementary data or instructions for a specific device.